MedTrace Logo

Evaluate the Interest of the Pre-conceptional Endometrial Immune Profiling to Increase Birth Rates

NCT02262117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-01-29

No results posted yet for this study

Summary

A prospective, randomized, controlled, open two-arm study to evaluate the interest of the pre-conceptional endometrial immune profiling to increase birth rates.

Conditions

  • Reproductive Medicine

Interventions

OTHER

standard care

No specific medical care

DRUG

specific treatment

Regarding the immune endometrial profiling, medical care (personalization of treatment) should follow a step by step decision tree.

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Nathalie LEDEE, MD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-30
Primary Completion
2024-03-22
Completion
2024-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262117 on ClinicalTrials.gov